Skip to Content
Biotechnology and health

These living bricks use bacteria to build themselves

January 16, 2020
An arch made from the living bricks
An arch made from the living bricksThe University of Colorado Boulder College of Engineering and Applied Science

The big idea: A new living substance can transform from a wet sand mixture into a solid brick, and even help to reproduce copies of itself.

How it was created: Researchers from the University of Colorado, Boulder, used a type of photosynthetic bacteria that absorbs carbon dioxide, sunlight, and nutrients and produces calcium carbonate—a rigid compound found in rocks, pearls, and seashells. They grew the bacteria in a warm mixture of salt water and other nutrients and combined it with sand and gelatin. The mixture was poured into a mold, and as it cooled the gelatin set, forming a “scaffold” able to support further bacterial growth. The bacteria deposited calcium carbonate throughout the scaffold, turning the soft sludge into a harder substance after about a day. The mixture looks green initially, but the color fades as it dries. The research was published in the journal Matter and was funded by DARPA, the US military's research arm.

Testing: The team cut the material into two-inch cubes and found they were strong enough for someone to stand on without shattering, although the material isn’t as strong as conventional concrete. Shoe-box-size blocks could potentially be strong enough for use as bricks in construction.

The potential: A major benefit of the new material, the researchers say, is that the whole process revolves around bacteria: they help build the bricks, and are kept alive so they are able to produce more bricks later on. The material could be useful for construction in inhospitable environments like the desert, or even space. It’s also a low-carbon alternative to concrete that could be used to make buildings that absorb greenhouse gases rather than releasing them.

Sign up here to our daily newsletter The Download to get your dose of the latest must-read news from the world of emerging tech. 

Deep Dive

Biotechnology and health

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

A biotech company says it put dopamine-making cells into people’s brains

The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.

Tiny faux organs could crack the mystery of menstruation

Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.

How AI can help us understand how cells work—and help cure diseases

A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.